Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-14
1995-07-18
Lone, Werren B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142268, 514393, 514395, 514365, 514 31, 546143, 546144, 546145, 546194, 546201, 546210, 546300, A61K 3147
Patent
active
054341639
ABSTRACT:
A method of treatment of Cryptococcus neoformans infection by administering to a patient in need thereof an effective amount of a benzimidazile compound.
REFERENCES:
patent: 3745187 (1973-07-01), Naguchi et al.
patent: 3769308 (1973-10-01), Kohmoto et al.
patent: 4725605 (1988-02-01), Crossley et al.
patent: 4794123 (1988-12-01), Crossley et al.
patent: 4863945 (1989-09-01), Crossley et al.
patent: 4952589 (1990-08-01), Brown
patent: 5061715 (1991-10-01), Sunkara
patent: 5151426 (1991-08-01), Bellene
patent: 5200417 (1993-04-01), Brown et al.
Cruz Maria C.
Edlind Thomas D.
Lentz Edward T.
Lone Werren B.
The Medical College of Pennsylvania
Williams Janice E.
LandOfFree
Treatment of Cryptococcus neoformans infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of Cryptococcus neoformans infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Cryptococcus neoformans infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2419105